BKYI Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q2

FY2025Q3

FY2025Q4

1.70M

+48.95%

-0.150

-85%

1.80M

-16.08%

-0.120

-69.23%

2.20M

+50.45%

-0.070

-86.79%

Estimates Revision

The market is revising No Change the revenue expectations for BIO-key International, Inc. (BKYI) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -19.31%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-19.31%

In Past 3 Month

1 Analyst Rating

Wall Street analysts forecast BKYI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BKYI is 2.00 USD with a low forecast of 2.00 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

2.00

Averages

2.00

High

2.00

Current: 0.000

Low

2.00

Averages

2.00

High

2.00

No data

Valuation Metrics

The current forward P/E ratio for BIO-Key International Inc (BKYI.O) is -1.62, compared to its 5-year average forward P/E of -9.18. For a more detailed relative valuation and DCF analysis to assess BIO-Key International Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-9.18

Current PE

-1.62

Overvalued PE

6.20

Undervalued PE

-24.56

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

1.22

Current PS

0.75

Overvalued PS

2.45

Undervalued PS

-0.01

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

BKYI News & Events

Events Timeline

No data

News

1.0

2025-12-23Globenewswire

BIO-key to Showcase IAM Solutions at 2025 Discovery Conference

3.5

2025-12-08Globenewswire

BIO-key Showcases Passwordless Authentication Technology at 2025 Gartner IAM Summit

3.5

2025-12-08Newsfilter

BIO-key Showcases Passwordless Authentication Solutions at 2025 Gartner IAM Summit

People Also Watch

Frequently Asked Questions

What is BIO-Key International Inc (BKYI) stock price today?

The current price of BKYI is 0.573 USD — it has decreased -5.13 % in the last trading day.

What is BIO-Key International Inc (BKYI)'s business?

BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.

What is the price predicton of BKYI Stock?

What is BIO-Key International Inc (BKYI)'s revenue for the last quarter?

BIO-Key International Inc revenue for the last quarter amounts to 1.55M USD, decreased -27.75 % YoY.

What is BIO-Key International Inc (BKYI)'s earnings per share (EPS) for the last quarter?

BIO-Key International Inc. EPS for the last quarter amounts to -0.15 USD, decreased -61.54 % YoY.

What changes have occurred in the market's expectations for BIO-Key International Inc (BKYI)'s fundamentals?

How many employees does BIO-Key International Inc (BKYI). have?

BIO-Key International Inc (BKYI) has 41 emplpoyees as of January 10 2026.

What is BIO-Key International Inc (BKYI) market cap?

Today BKYI has the market capitalization of 6.21M USD.